Institutional Ownership Karyopharm Therapeutics Inc. (KPTI)
This table provides information about the institutional ownership of Karyopharm Therapeutics Inc. (KPTI). We have compiled data on the 7 institutions that hold shares in the stock, with a total of 4.39 Million shares, which have been reported (via 13F filing form) to have a value of $17.6 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,169,788
shares
|
$16.8 Million
0.0% of portfolio
|
Q2 2024
Reduced 55.86%
|
|
Jefferies Group LLC
New York, NY |
Sep 21, 2023 Q3 2022 |
101,700
shares
|
$408,833
0.01% of portfolio
|
Q3 2022
Added 101600.0%
|
|
Wade G W & Inc
Wellesley, MA |
Feb 08, 2024 Q4 2023 |
45,140
shares
|
$181,462
0.0% of portfolio
|
Q3 2023
New holding
|
|
Sawtooth Solutions, LLC
|
Jan 29, 2024 Q4 2023 |
37,938
shares
|
$152,510
0.0% of portfolio
|
Q4 2023
New holding
|
|
Birchview Capital, LP
Burlington, VT |
Aug 14, 2025 Q2 2025 |
27,985
shares
|
$112,499
0.13% of portfolio
|
Q4 2024
Reduced 10.64%
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Aug 13, 2025 Q2 2025 |
4,879
shares
|
$19,613
0.0% of portfolio
|
Q2 2025
New holding
|
|
Janiczek Wealth Management, LLC
|
Jul 25, 2024 Q2 2024 |
17
shares
|
$68
0.0% of portfolio
|
Q4 2023
New holding
|